Social services
Health and Human Services Secretary Robert F. Kennedy Jr. has removed all 17 members of the Advisory Committee for Immunization Practices, a decision aimed at restoring "public trust above any pro-or antivaccine agenda." Kennedy, a vaccine skeptic, claims that the committee has been plagued by conflicts of interest
Vaccination
The Department of Health (DOH) has experienced a significant delay in vaccine procurement, with no contracts awarded six months after the start of the procurement process in January 2024. This delay has raised concerns about the country's ability to meet its ambitious health care goals, particularly in achieving
COVID-19
Public health officials are sharply criticizing a new guidance issued by Health and Human Service Secretary Robert F. Kennedy Jr. that advises against COVID-19 vaccinations for healthy children and pregnant women. The new recommendations, issued just days before a key committee meeting to review vaccine evidence, have sparked widespread concern
COVID-19
The US Centers for Disease Control and Prevention (CDC) has updated its immunization schedule for children, following a surprise announcement by US Health and Human Services Secretary Robert F. Kennedy Jr. that COVID-19 vaccines would be removed from the recommended shots for healthy children and pregnant women. However, the changes
COVID-19
Public health experts and organizations are raising concerns about recent announcements from the Health and Human Services Secretary and the FDA regarding the COVID-19 vaccine policy. The changes aim to limit vaccine recommendations to individuals with high-risk conditions, rather than a universal vaccination strategy. This shift may make it difficult
COVID-19
Advocates for pregnant people are sounding the alarm over Robert F Kennedy Jr's unexpected and unilateral decision to remove Covid-19 booster shots from the recommended immunization schedule. This move is crucial for patient access, as many private health insurance plans determine which vaccines to cover based on the
COVID-19
The Centre for Health Protection (CHP) of the Department of Health in Hong Kong has confirmed a severe paediatric case of COVID-19 in a 1-year-old girl who has developed fever and runny nose. The patient had not received COVID-19 vaccine and had no travel history during the incubation period. The
COVID-19
Researchers at Regeneron Pharmaceuticals Inc. have explored the use of lipid nanoparticles (LNPs) in the delivery of nucleic acids, including the first RNAi drug and two COVID-19 mRNA vaccines approved by the FDA. Despite their advantages, challenges such as liver accumulation and difficulties in quality control persist for LNP development.
COVID-19
Research conducted by the University of Nottingham has found that temporarily suspending methotrexate treatment for two weeks after the COVID-19 booster vaccine can enhance antibody responses in people with immune-mediated inflammatory diseases. The study, funded by the National Institute for Health and Care Research (NIHR) Efficacy and Mechanism Evaluation programme,
COVID-19
The US Food and Drug Administration has announced changes to how it approves Covid-19 vaccines for Americans, potentially limiting access to updated shots for older adults and those at higher risk of severe Covid-19 infection. This move aims to approve updated Covid-19 shots for adults 65 and older and those
COVID-19
Germany-based Biopharmaceutical company BioNTech will invest up to £1 billion in the UK over the next decade, a move that will create hundreds of high-skilled jobs and fund new research centres. The planned investment will see the establishment of two new research and development hubs, one in Cambridge and an
COVID-19
The FDA has announced a significant policy change, requiring more robust scientific studies before approving updated COVID-19 vaccines for healthy adults under age 65. This move is expected to limit access to the shots for lower-risk individuals, prioritizing those at higher risk of serious infections, such as seniors and individuals
